TITLE

Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine

AUTHOR(S)
Ramaswamy, Krishnan; Kozma, Chris M.; Nasrallah, Henry
PUB. DATE
May 2007
SOURCE
Drug Safety;2007, Vol. 30 Issue 7, p589
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Atypical antipsychotics have been associated with metabolic abnormalities including impaired glucose metabolism, exacerbation of existing diabetes mellitus and new-onset type 2 diabetes. Not all atypical antipsychotic agents appear to have the same propensity to cause these complications.Objective: To assess diabetic ketoacidosis risk in patients receiving risperidone or olanzapine.Methods: California Medicaid data were evaluated for the presence of a diabetic ketoacidosis hospital claim (9th Edition of the International Classification of Diseases code 2501x) for patients receiving an atypical antipsychotic agent between July 1997 and September 2000. Initial prescription claims were identified for risperidone, olanzapine, clozapine, quetiapine and multiple atypical medications; however, the final analysis was restricted to risperidone and olanzapine owing to sample size challenges in the clozapine and quetiapine groups. Cases were specified if a claim occurred within 45 days after antipsychotic dispensation. Potential confounding variables and duration of antipsychotic exposure were included.Results: Initial users of risperidone (n = 51,330; 31 diabetic ketoacidosis) and olanzapine (n = 51,302; 55 diabetic ketoacidosis) were identified between July 1997 and September 2000. The adjusted risk of diabetic ketoacidosis for olanzapine versus risperidone was 1.62 (p = 0.033). The risk of diabetic ketoacidosis was associated with a longer duration of drug exposure. A progressive and statistically significant divergence in risk was observed between the two treatment groups after the first 30 days of therapy. For risperidone patients, diabetic ketoacidosis risk stabilised after the first 90 days; for olanzapine patients, diabetic ketoacidosis risk continued to increase until 360 days (study duration). For exposures of >30 days, >90 days and >180 days, diabetic ketoacidosis risk was 1.7 (p = 0.026), 2.4 (p = 0.004) and 3.5 (p = 0.001) times greater for olanzapine than risperidone. Treatment group, age, African American race and the presence of schizophrenia or diabetes were significant predictors of diabetic ketoacidosis.Conclusion: The risk of diabetic ketoacidosis appears to be greater for patients exposed to olanzapine compared with risperidone after adjusting for confounding factors. This risk appears to increase with longer duration of exposure to olanzapine.
ACCESSION #
25740046

 

Related Articles

  • Weight gain and new onset diabetes associated with olanzapine and risperidone. Farwell, Wildon R.; Stump, Timothy E.; Wang, Jane; Tafesse, Eskinder; L'Italien, Gilbert; Tierney, William M. // JGIM: Journal of General Internal Medicine;Dec2004, Vol. 19 Issue 12, p1200 

    Objective: To assess whether newer antipsychotic medications are associated with weight gain and development of diabetes.Design: Retrospective cohort study.Setting: Data from a comprehensive electronic medical record serving an urban public hospital and a...

  • Olanzapine for patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. Dursun, Serdar M; Gardner, David M; Bird, Diane C; Flinn, Janet; Dursun, S M; Gardner, D M; Bird, D C; Flinn, J // Canadian Journal of Psychiatry;Sep1999, Vol. 44 Issue 7, p701 

    Objective: This prospective, consecutive case-series outcome investigation evaluates the effectiveness of olanzapine in 16 patients with treatment-resistant schizophrenia. Method: Treatment resistance was defined as nonresponsiveness to at least 3 antipsychotic drugs...

  • Olanzapine use in the elderly: a retrospective analysis. Solomons, Kevin; Geiger, Odie; Solomons, K; Geiger, O // Canadian Journal of Psychiatry;Mar2000, Vol. 45 Issue 2, p151 

    Objective: To evaluate the efficacy and safety of olanzapine in a hospitalized geriatric population that had previously failed to respond to, or tolerate, numerous trials with other antipsychotic medications. Method: A retrospective chart analysis was conducted on 58...

  • Diabetic Ketoacidosis and Related Events in the Canaglif lozin Type 2 Diabetes Clinical Program. Erondu, Ngozi; Desai, Mehul; Ways, Kirk; Meininger, Gary // Diabetes Care;Sep2015, Vol. 38 Issue 9, p1680 

    OBJECTIVE This study assessed the incidence of serious adverse events of diabetic ketoacidosis (DKA) among patients with type 2 diabetes treated with canagliflozin. RESEARCH DESIGN AND METHODS All serious adverse events of DKA and related events (ketoacidosis, metabolic acidosis, and acidosis)...

  • The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study. Huang, Elbert S.; Karter, Andrew J.; Danielson, Kirstie K.; Warton, E. Margaret; Ahmed, Ameena T. // JGIM: Journal of General Internal Medicine;Feb2010, Vol. 25 Issue 2, p141 

    Background: Use of four or more prescription medications is considered a risk factor for falls in older people. It is unclear whether this polypharmacy-fall relationship differs for adults with diabetes.Objective: We evaluated the association between number of...

  • Health-related quality of life in urban African Americans with type 2 diabetes. Hill-Briggs, Felicia; Gary, Tiffany L.; Hill, Martha N.; Bone, Lee R.; Brancati, Frederick L. // JGIM: Journal of General Internal Medicine;Jun2002, Vol. 17 Issue 6, p412 

    Objective: To examine the association of socioeconomic barriers, familial barriers, and clinical variables with health-related quality of life (HRQL).Methods: A cross-sectional study was conducted of 186 African Americans with type 2 diabetes recruited from 2 primary...

  • Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. Singh, Rishi P; Gans, Richard; Kashyap, Sangeeta R; Bedi, Rumneek; Wolski, Kathy; Brethauer, Stacy A; Nissen, Steven E; Bhatt, Deepak L; Schauer, Philip // Diabetes Care;Mar2015, Vol. 38 Issue 3, pe32 

    No abstract available.

  • Relation between increased anaerobic glycolysis and visual acuity in long-standing type 2 diabetes mellitus without retinopathy. Mondal, L. K.; Baidya, K. P.; Bhattacharya, B.; Giri, A.; Bhaduri, G. // Indian Journal of Ophthalmology;Mar2006, Vol. 54 Issue 1, p43 

    In long-standing diabetes mellitus, blood flow to essential organs including the retina is reduced owing to macrovascular and/or microvascular changes. Poor glycolytic pathway of glucose metabolism owing to tissue hypoxia caused by ischemia at capillary bed of essential organs produces excessive...

  • Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Hundal, Ripudaman S; Petersen, Kitt F; Mayerson, Adam B; Randhawa, Pritpal S; Inzucchi, Silvio; Shoelson, Steven E; Shulman, Gerald I // Journal of Clinical Investigation;5/1/2002, Vol. 109 Issue 9, p1321 

    Recent studies have implicated fatty acid-dependent activation of the serine kinase IKKbeta, which plays a key role in tissue inflammation, in the pathogenesis of insulin resistance. High doses of salicylates have recently been shown to inhibit IKKbeta activity and might therefore ameliorate...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics